• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6-80-PTX
Device Problem Occlusion Within Device (1423)
Patient Problems Occlusion (1984); Surgical procedure (2357); Claudication (2550)
Event Date 08/26/2014
Event Type  Injury  
Event Description
Patient is participating in a (b)(4) study (b)(4) and had a zilver ptx stent placed in their left proximal sfa.The patient went in for medical evaluation on (b)(6) 2014 due to worsening claudication/rest pain.An ultrasound was performed at this visit and showed an occlusion proximal, within and distal to the study lesion.On (b)(6) 2014, an angiogram was performed and the physician was unable to cross the lesion and consequently there was no treatment of the occlusion.The patient then became a candidate for bypass surgery.The comment on the ae form states: "all stents occluded per angio and duplex - no intervention performed possible leg bypass in future." the patient presented for their 12 month follow-up clinical assessment, x-ray and duplex ultrasound on (b)(6) 2014.The duplex ultrasound findings show an occlusion proximal, within & distal to the study lesion.The x-ray of the study stents and nonstudy stent were negative for evidence of fracture.The patient remains a candidate for bypass surgery.The information received relating to this event is currently being investigated.A follow up mdr will be submitted with the investigation conclusions.
 
Manufacturer Narrative
Pma/510(k)#: p100022 and s001.(b)(4).Incident requires fda mdr report based on the surgical intervention planned (planned bypass surgery) in response to the occlusion within the lesion where a zilver ptx stent was indwelling.The information received relating to this event is currently being investigated.A follow up mdr will be submitted with the investigation conclusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX 35 DRUG-ELUTING STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid
61334440
MDR Report Key4370142
MDR Text Key5234730
Report Number3001845648-2014-00340
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/11/2013
Device Catalogue NumberZIV6-35-125-6-80-PTX
Device Lot NumberC936025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date08/26/2014
Event Location Hospital
Date Manufacturer Received12/09/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/15/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-